Monday, November 2, 2026

North Korea Echoes China in Attack on Expanded U.S. Forces Role in South Korea

North Korea criticizes U.S. military leaders' comments, aligning with China, as relations between Pyongyang and Beijing deepen.

K-Pop Star Hwasa Makes History as First Female Solo Artist to Perform at Rock in Rio 2026

Singer Hwasa becomes the first K-pop female solo artist to perform on the main stage at Brazil's Rock in Rio festival.

News1

Celltrion’s Truxima becomes first rituximab biosimilar in U.S. to receive interchangeability designation

Celltrion's Truxima gains FDA interchangeability status, enhancing its market position and credibility in blood cancer treatment.

Bukwang Pharmaceutical builds turnaround momentum, eyes Parkinson’s drug progress in second half

Bukwang Pharmaceutical is advancing its Parkinson’s treatment CP-012 into a global Phase 2 trial while enhancing RNA technology and manufacturing.

K-Bio shifts focus to clinical data as key trial readouts stack up in second half

Korea's biotech sector shifts focus to clinical data in H2 2023, with key results from leading companies expected to drive investor sentiment.

Discover the Future: SK Intellix Launches AI Wellness Robot NAMUHX with My Healthcare Service

SK Intellix integrates AI health consultations into its NAMUHX wellness robot, offering personalized health advice and vital sign checks.

2025 HIV/AIDS Report: New Infections Drop by 4.9% – What You Need to Know

South Korea saw a 4.9% drop in new HIV infections in 2025, with 99% of cases linked to sexual contact, highlighting the need for testing.

2026’s Game-Changer: Inventage Lab’s BioFluidic Technology Revolutionizes Antibody Drug Administration

Inventage Lab's CEO emphasizes the importance of platform technology for drug delivery systems and open innovation in the pharmaceutical industry.

K-Health Revolution: How Korean AI is Transforming Vietnam’s Healthcare Market

A South Korean digital healthcare firm secured an export deal in Vietnam, enhancing Korean AI medical services' global presence.

SK Chemicals and J2H Biotech Partner for Breakthrough MASH Treatment: What You Need to Know

SK Chemicals partners with J2H Biotech to develop J2H-1702, a treatment for metabolic-associated steatotic liver disease, enhancing drug pipeline.

Unlocking Cancer Treatment: Samsung Bioepis Achieves Keytruda Biosimilar Equivalence in Global Trials

Samsung Bioepis' biosimilar SB27 shows equivalence to Keytruda in key clinical trials, enhancing access to cancer immunotherapy.

AI Infrastructure Crisis: How Google’s Limit on Meta’s Gemini Model Highlights a Global Computing Bottleneck

Google limits Meta's AI model access due to computing shortages, impacting key projects and shifting focus to efficiency in AI usage.

Samsung Electro-Mechanics Secures 450 Million KRW MLCC Supply Deal for AI Servers: What This Means for the Tech Industry

Samsung Electro-Mechanics has signed a $290M deal for MLCCs for AI servers, aiming to expand its product portfolio and market share.

Samsung’s New Education Solutions: How the Latest AI Assistant App Transforms Learning in 2026

Samsung Electronics showcased innovative educational solutions at ISTE Live, enhancing interactive displays for personalized learning environments.

D-RAM Price Fixing: Samsung, SK Hynix, and Micron Face Lawsuit Over 700% Price Surge

U.S. consumers and businesses sue Samsung, SK Hynix, and Micron for allegedly colluding to inflate DRAM prices by 700%.

High cost keeps breakthrough VHL drug out of reach for Korean patients, oncologist says

Patients with Von Hippel-Lindau syndrome face high treatment costs, limiting access to essential drugs like Welireg, which could reduce surgeries.

Top News

- Our Sponsors Ad -

Follow us